Personal information

No personal information available

Activities

Works (14)

Perioperative immunotherapy plus chemotherapy versus chemotherapy alone for patients with resectable pulmonary lymphoepithelioma-like carcinoma

Lung Cancer
2025-01 | Journal article
Contributors: Mengjie Lei; Xuanye Zhang; Li-na Hu; Sha Fu; Meihua Xiao; Zhiqing Long; Honglin Zhu; Yixin Zhou; Shaodong Hong
Source: check_circle
Crossref

Adjuvant therapy in completely resected, EGFR-mutant non-small cell lung cancer: a comparative analysis of treatment efficacy between EGFR-TKI and anti-PD-1/PD-L1 immunotherapy

Journal for ImmunoTherapy of Cancer
2023-10 | Journal article
Contributors: Zichun Li; Xuanye Zhang; Yuhong Wang; Zhixin Yu; Chunlong Yang; Yixin Zhou; Shaodong Hong
Source: check_circle
Crossref

Optimizing the tumor shrinkage threshold for evaluating immunotherapy efficacy for advanced non-small-cell lung cancer

Journal of Cancer Research and Clinical Oncology
2023-03 | Journal article
Contributors: Wei Du; Chen Chen; Lin-feng Luo; Li-na He; Yixing Wang; Xuanye Zhang; Yixin Zhou; Zuan Lin; Shaodong Hong
Source: check_circle
Crossref

Correction to: Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus

Cancer Immunology, Immunotherapy
2022-05 | Journal article
Contributors: Zuan Lin; Xuanye Zhang; Yixin Zhou; Chen Chen; Li-na He; Haifeng Li; Yuhong Wang; Tao Chen; Shaodong Hong; Li Zhang
Source: check_circle
Crossref

Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus

Cancer Immunology, Immunotherapy
2022-05 | Journal article
Contributors: Zuan Lin; Xuanye Zhang; Yixin Zhou; Chen Chen; Li-na He; Haifeng Li; Yuhong Wang; Tao Chen; Shaodong Hong; Li Zhang
Source: check_circle
Crossref

Efficacy and safety of PD-L1 inhibitors versus PD-1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer

Cancer Immunology, Immunotherapy
2022-03 | Journal article
Contributors: Hui Yu; Ping Chen; Xiuyu Cai; Chen Chen; Xuanye Zhang; Lina He; Yixin Zhou; Shaodong Hong; Bei Zhang
Source: check_circle
Crossref

Optimizing the Tumor Shrinkage Threshold for Evaluating Immunotherapy Efficacy for Advanced Non-Small-Cell Lung Cancer

2022-02-15 | Preprint
Contributors: Wei Du; Chen Chen; Lin-feng Luo; Li-na He; Yixing Wang; Xuanye Zhang; Yixin Zhou; Zuan Lin; Shaodong Hong
Source: check_circle
Crossref

PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancer

Journal for ImmunoTherapy of Cancer
2021-11 | Journal article
Contributors: Hui Yu; Ping Chen; Liangping Xia; Sha Fu; Chen Chen; Xuanye Zhang; Lina He; Bei Zhang; Yixin Zhou; Shaodong Hong
Source: check_circle
Crossref

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Journal of Clinical Oncology
2021-10-10 | Journal article
Contributors: Shaodong Hong; Yaxiong Zhang; Gengsheng Yu; Peijian Peng; Jiewen Peng; Jun Jia; Xuan Wu; Yan Huang; Yunpeng Yang; Qing Lin et al.
Source: check_circle
Crossref

Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma

Journal for ImmunoTherapy of Cancer
2021-03 | Journal article
Contributors: Yuxiang Ma; Xi Chen; Ao Wang; Hongyun Zhao; Qingguang Lin; Hua Bao; Yang Zhang; Shaodong Hong; Wanxiangfu Tang; Yan Huang et al.
Source: check_circle
Crossref

First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy

Journal for ImmunoTherapy of Cancer
2019-12 | Journal article
Contributors: Yixin Zhou; Zuan Lin; Xuanye Zhang; Chen Chen; Hongyun Zhao; Shaodong Hong; Li Zhang
Source: check_circle
Crossref

Progression‐free survival and one‐year milestone survival as surrogates for overall survival in previously treated advanced non‐small cell lung cancer

International Journal of Cancer
2019-06 | Journal article
Contributors: Shen Zhao; Zhonghan Zhang; Yaxiong Zhang; Shaodong Hong; Ting Zhou; Yunpeng Yang; Wenfeng Fang; Hongyun Zhao; Li Zhang
Source: check_circle
Crossref

Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study

Cancer Medicine
2019-04 | Journal article
Contributors: Jiaqing Liu; Huaqiang Zhou; Yaxiong Zhang; Yan Huang; Wenfeng Fang; Yunpeng Yang; Shaodong Hong; Gang Chen; Shen Zhao; Xi Chen et al.
Source: check_circle
Crossref

A large, single‐center, real‐world study of clinicopathological characteristics and treatment in advanced ALK‐positive non‐small‐cell lung cancer

Cancer Medicine
2017-05 | Journal article
Contributors: Gang Chen; Xi Chen; Yaxiong Zhang; Fang Yan; Wenfeng Fang; Yunpeng Yang; Shaodong Hong; Siyu Miao; Manli Wu; Xiaodan Huang et al.
Source: check_circle
Crossref

Peer review (9 reviews for 3 publications/grants)

Review activity for BMC medicine (2)
Review activity for Cell reports medicine. (2)
Review activity for Lung cancer. (5)